blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3639843

EP3639843 - APOO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.11.2021
Database last updated on 09.09.2024
FormerExamination is in progress
Status updated on  22.01.2021
FormerRequest for examination was made
Status updated on  20.03.2020
Most recent event   Tooltip26.11.2021Application deemed to be withdrawnpublished on 29.12.2021  [2021/52]
Applicant(s)For all designated states
Rouet, Philippe
485 chemin de riverotte
31810 Clermont le fort / FR
For all designated states
Smih-Rouet, Fatima
485 chemin de riverotte
31810 Clermont le fort / FR
[2020/17]
Inventor(s)01 / see applicant
...
 [2020/17]
Representative(s)Plasseraud IP
104 Rue de Richelieu
CS92104
75080 Paris Cedex 02 / FR
[N/P]
Former [2020/17]Plasseraud IP
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
Application number, filing date19214261.015.04.2015
[2020/17]
Priority number, dateEP2014030556516.04.2014         Original published format: EP 14305565
[2020/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3639843
Date:22.04.2020
Language:EN
[2020/17]
Search report(s)(Supplementary) European search report - dispatched on:EP12.02.2020
ClassificationIPC:A61K38/17, A61P35/00, A61P3/00
[2020/17]
CPC:
A61K38/1709 (EP,US); A61K38/1716 (EP,US); A61P35/00 (EP,US);
C07K16/18 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/17]
TitleGerman:APOO ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG VON KREBS UND VERSCHIEDENEN PATHOPHYSIOLOGISCHEN ZUSTÄNDEN[2020/17]
English:APOO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS[2020/17]
French:APOO POUR UTILISATION DANS UN PROCÉDÉ DE TRAITEMENT DU CANCER ET DIVERSES SITUATIONS PATHOPHYSIOLOGIQUES[2020/17]
Examination procedure06.12.2019Examination requested  [2020/17]
22.10.2020Amendment by applicant (claims and/or description)
25.01.2021Despatch of a communication from the examining division (Time limit: M06)
05.08.2021Application deemed to be withdrawn, date of legal effect  [2021/52]
25.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/52]
Parent application(s)   TooltipEP15716524.2  / EP3131569
Fees paidRenewal fee
06.12.2019Renewal fee patent year 03
06.12.2019Renewal fee patent year 04
06.12.2019Renewal fee patent year 05
27.10.2020Renewal fee patent year 06
09.04.2021Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.04.202006   M06   Fee paid on   27.10.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2013183964  (UNIV SOGANG IND UNIV COOP FOUN [KR]) [Y] 1-15 * the whole document * * claim 12 *;
 [I]WO2012072681  (INST NAT SANTE RECH MED [FR], et al) [I] 1-15 * the whole document * * claims 9-10 * * page 29, line 18 * * page 16, lines 5-6 *;
 [XP]  - TURKIEH ANNIE ET AL, "Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart.", THE JOURNAL OF CLINICAL INVESTIGATION 1 MAY 2014, (20140501), vol. 124, no. 5, ISSN 1558-8238, pages 2277 - 2286, XP002725819 [XP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI74668
 [Y]  - CHEN-LU WU ET AL, "Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line", LIPIDS IN HEALTH AND DISEASE, BIOMED CENTRAL, LONDON, GB, (20131217), vol. 12, no. 1, doi:10.1186/1476-511X-12-186, ISSN 1476-511X, page 186, XP021171320 [Y] 1-15 * the whole document * * abstract *

DOI:   http://dx.doi.org/10.1186/1476-511X-12-186
 [Y]  - MATTHIEU LAMANT ET AL, "ApoO, a Novel Apolipoprotein, Is an Original Glycoprotein Up-regulated by Diabetes in Human Heart", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 281, no. 47, doi:10.1074/JBC.M510861200, ISSN 0021-9258, (20061124), pages 36289 - 36302, (20060906), XP002627267 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.M510861200
by applicantUS4946778
 US5225539
 US4816397
 US6573099
 US6506559
 WO0136646
 WO9932619
 WO0168836
    - "database", Database accession no. NM_024122
    - CARTER et al., Nucl. Acids Res., (19850000), vol. 13, page 4331
    - HARMANCEY, R. et al., "western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis", J Lipid Res, (20100000), vol. 51, pages 1380 - 1393
    - HICKSON-BICK et al., J Mol Cell Cardiol, (20000000), vol. 32, pages 511 - 519
    - HIROTA et al., Life Sci, (20060000), vol. 79, pages 1312 - 1316
    - ASKARI, B. et al., Diabetes, (20070000), vol. 56, pages 1143 - 1152
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.